The global acromegaly treatment market was valued at USD 1,304.4 Million in 2019 and is projected to reach USD 2,299.4 Million by 2027, expanding at a CAGR of 7.6% during the forecast period. Acromegaly is rare acquired endocrine disease which is related to excessive production of growth hormone (GH) and it is characterized by progressive systemic manifestation and somatic disfigurement (it involves the extremities and face).
Request Free Sample Report Here
Market Dynamics
The market is driven by factors such as rising prevalence of acromegaly, growing number of hormonal diseases, rising number of clinical trials, and increasing awareness among people for acromegaly. Conversely, high cost for treatment and lack of awareness and infrastructure in under developed countries are acting as key restraints of this market. Untapped opportunities in emerging countries and rising investment in research and development are expected to create opportunities for market in the future.
Segmental Outlook
On the basis of products, the acromegaly treatment market is divided into somatostatin analogs, growth hormone receptor antagonist (GHRA), and dopamine agonist. The somatostatin analogs are anticipated to expand at a CAGR of 7.9% during the forecast period due to the wide availability of drugs and cost efficiency. The growth hormone receptor antagonist segment is estimated to hold around 1/5th share of the market in 2020 owing to the inclusion of genetically engineered growth hormone which is used for blocking the dimerization of GH receptor.
Regional Outlook
In terms of regions, the global acromegaly treatment market is fragmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Asia Pacific is a promising region for the market. The region constituted 1/5 of the market in 2020. The market in the region is projected to expand at a CAGR of 8.0% during the forecast period. Rising awareness regarding hormone-related diseases and rising healthcare expenditure are driving the acromegaly treatment market in Asia Pacific. The market in North America is projected to expand at a CAGR of 7.5% due to growing prevalence of acromegaly in the region. According to the American Society of Clinical Oncology (ASCO) in the US, 14,230 people were diagnosed with pituitary gland tumor in 2017.
Competitive Landscape
Key players in the global acromegaly treatment market includes Novartis AG, Sun Pharmaceutical Industries Ltd., DAEWOONG PHARMACEUTICAL CO.,LTD., Dauntless Pharmaceuticals, and WOCKHARDT. These companies are considered as key manufacturers of acromegaly treatment drugs, based on their revenue, research & development activities, regional presence, and supply chain management system.
The players are adopting key strategies such as acquisition, and geographical expansion where potential opportunity for the Acromegaly Treatment extraction is added in the company’s capacity.
About Growth Market Reports:
GROWTH MARKET REPORTS provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Industry Intelligence Solutions”. GROWTH MARKET REPORTS has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain. Our key analysis segments, though not restricted to the same, include market entry strategies, market size estimations, market trend analysis, market opportunity analysis, market threat analysis, market growth/fall forecasting, primary interviews, secondary research & consumer surveys.
Contact:
Growth Market Reports
Phone: +1 909 414 1393
Email: [email protected]
Web: https://growthmarketreports.com
With a multi-disciplinary approach, Fact.MR elaborates an extensive analysis of the historical, current and future outlook of the global acromegaly treatment market as well as the factors responsible for such a growth.
Our highly dedicated professionals have inputted critical and accurate insights associated with every industry, and region by doing thorough primary and secondary research.We leverage space-age industrial and digitalization tools to provide avant-garde actionable insights to our clients regarding the acromegaly treatment market.
For enhancing readers’ experience, the report starts with a basic overview about the acromegaly treatment market and its classification.
Further, we have considered 2018 as the base year, 2019 as the estimated year, 2019 – 2029 as the stipulated timeframe.Competitive Assessment The acromegaly treatment market report includes global as well as emerging players:Pfizer IncRoche Holding AGNovartis International AGDexTech Medical ABSun Pharmaceuticals Industries LtdChiasma, IncThe insights for each vendor consists of:Company profileSWOT analysisMain market informationMarket shareRevenue, pricing and gross marginRequest for the Sample of the Report: https://www.factmr.com/connectus/sample?flag=S_id=2191Regional Analysis Important regions covered in the acromegaly treatment market report include:North America (U.S., Canada)Latin America (Brazil, Mexico, Argentina, Chile, Peru, Rest of LATAM)EU – (Germany, France, Italy, Spain), UK, BENELUX (Belgium, Netherlands, Luxemburg), NORDIC (Norway, Denmark, Iceland, Sweden), Eastern Europe (Poland, Ukraine, Czech Rep.
), Rest of EuropeCIS & RussiaJapanAsia Pacific Excluding Japan (Greater China, India, S. Korea, ASEAN Countries, Rest of APEJ)Middle East and Africa (GCC Countries, Turkey, Iran, Israel, South Africa , Rest of MEA)The acromegaly treatment market report also provides data regarding the key countries in the defined regions.Segmentation AnalysisBy Treatment:Somatostatin analoguesDopamine agonistsGrowth hormone receptor antagonistsOthersBy Distribution Channel:Hospitals PharmaciesRetail PharmaciesWhat insights does the acromegaly treatment market report provide to the readers?Acromegaly treatment market fragmentation on the basis of product type, end use, and region.Comprehensive assessment of upstream starting materials, downstream demand, and present market landscape.Collaborations, R projects, acquisitions, and product launches of each acromegaly treatment market player.Various regulations imposed by the governments on the consumption of acromegaly treatment market in detail.Impact of modern technologies, such as big data & analytics, artificial intelligence, and social media platforms on the global acromegaly treatment market.Request TOC of this Report - https://www.factmr.com/connectus/sample?flag=T_id=2191Questionnaire answered in the acromegaly treatment market report include:What is the present and future outlook of the global acromegaly treatment market on the basis of region?What are the challenges and opportunities for the acromegaly treatment market?Why the consumption of acromegaly treatment market highest in region?In which year segment is expected to overtake segment?
The disease acromegaly is not so innocent like the name might suggest.
This disease is actually a disorder which results from the excess growth hormone after the closure of the growth plates.
The disease has initial symptoms like the enlargement of the hands and the enlargement of the feet.
